EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer

Jing Cao iD, Xiaobo Wang, Shouman Wang, Zihua Chen, Jianing Tang iD

Cancer Science · 2023

DOI: 10.1111/cas.15613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Jing Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Estrogen Receptor alpha, Endopeptidases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese International Postdoctoral Exchange Fellowship Program (Talent-Introduction Program).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a major cause of cancer‐related morbidity and mortality in women. Estrogen receptor‐positive breast cancer accounts for roughly 70%‐80% of breast tumors, and estrogen receptor alpha (ERα) has been considered as a key driver in promoting breast cancer progression. In the present study, we identified USP37 as a novel modulator in modulating ERα ubiquitination and stability. The expression of USP37 was upregulated in ERα‐positive breast cancer and correlated with ERα protein level. High expression of USP37 was associated with unfavorable prognosis. USP37 depletion resulted in significantly decreased ERα protein level, ERα target genes expression as well as the estrogen response element activity in breast cancer cells. Further mechanistic study revealed the interaction between USP37 and ERα: USP37 regulated ERα signaling through modulating protein stability instead of gene expression, in which it stabilized ERα protein via inhibiting the K48‐specific polyubiquitination process. Additionally, USP37 depletion led to growth inhibition and cell cycle arrest of ERα‐positive breast cancer cells, which could be further rescued by ERα overexpression. Overall, our study proposed a novel post‐translational mechanism of ERα in promoting breast cancer progression. Targeting USP37 may be proved to be a promising strategy for patients with ERα‐positive breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEstrogen Receptor alphaEndopeptidasesFemaleHumansBreastCell Line, TumorEstrogensGene Expression Regulation, NeoplasticMCF-7 Cells

Stichwörter der Autor:innen

USP37breast cancerdeubiquitylationestrogen receptor α (ERα)stabilization

Substanzen

Estrogen Receptor alphaEstrogensUSP37 protein, humanEndopeptidases

Autor:innen und Institutionen

  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
  • Multidisciplinary Breast Cancer Center, Xiangya Hospital, Central South University, Changsha, China.
  • Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • The Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Changsha, China.
  • Department of Liver Surgery, Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: Jing Cao, Jianing Tang

Förderung

  • Chinese International Postdoctoral Exchange Fellowship Program (Talent-Introduction Program)

Zitieren

APA

Cao, J., Wang, X., Wang, S., Chen, Z., & Tang, J. (2023). Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. Cancer Science. https://doi.org/10.1111/cas.15613

Vancouver

Cao J, Wang X, Wang S, Chen Z, Tang J. Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. Cancer Science. 2023. doi:10.1111/cas.15613

BibTeX
@article{Cao2023,
  author = {Cao, Jing and Wang, Xiaobo and Wang, Shouman and Chen, Zihua and Tang, Jianing},
  title = {Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15613}
}
Kostenlos starten →